Status: retired, Primitive. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2819079017 | Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 2819080019 | Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet (product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Some | ||
| Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet | Is a | Carbidopa- and entacapone- and levodopa-containing product | false | Inferred relationship | Some | ||
| Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet | Has active ingredient | Entacapone | false | Inferred relationship | Some | ||
| Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet | Has active ingredient | Levodopa | false | Inferred relationship | Some | ||
| Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet | Has active ingredient | Carbidopa | false | Inferred relationship | Some | ||
| Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Some | ||
| Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet | Is a | Carbidopa- and entacapone- and levodopa-containing product in oral dose form | false | Inferred relationship | Some | ||
| Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR